- Home
- JVA vs LPCN Comparison
JVA vs LPCN Comparison
Compare JVA & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- LPCN
- Stock Information
- Founded
- JVA 1971
- LPCN 1997
- Country
- JVA United States
- LPCN United States
- Employees
- JVA N/A
- LPCN N/A
- Industry
- JVA Packaged Foods
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- LPCN Health Care
- Exchange
- JVA Nasdaq
- LPCN Nasdaq
- Market Cap
- JVA 19.5M
- LPCN 16.1M
- IPO Year
- JVA 2005
- LPCN N/A
- Fundamental
- Price
- JVA $3.37
- LPCN $3.16
- Analyst Decision
- JVA
- LPCN Strong Buy
- Analyst Count
- JVA 0
- LPCN 1
- Target Price
- JVA N/A
- LPCN $10.00
- AVG Volume (30 Days)
- JVA 74.8K
- LPCN 22.1K
- Earning Date
- JVA 06-16-2025
- LPCN 05-08-2025
- Dividend Yield
- JVA N/A
- LPCN N/A
- EPS Growth
- JVA 6252.13
- LPCN N/A
- EPS
- JVA 0.53
- LPCN N/A
- Revenue
- JVA $80,327,181.00
- LPCN $3,674,834.00
- Revenue This Year
- JVA N/A
- LPCN N/A
- Revenue Next Year
- JVA N/A
- LPCN N/A
- P/E Ratio
- JVA $6.67
- LPCN N/A
- Revenue Growth
- JVA 15.77
- LPCN N/A
- 52 Week Low
- JVA $1.23
- LPCN $2.75
- 52 Week High
- JVA $9.93
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- JVA 46.20
- LPCN 48.60
- Support Level
- JVA $3.06
- LPCN $2.68
- Resistance Level
- JVA $3.48
- LPCN $3.46
- Average True Range (ATR)
- JVA 0.26
- LPCN 0.33
- MACD
- JVA 0.05
- LPCN -0.02
- Stochastic Oscillator
- JVA 40.26
- LPCN 51.97
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.